French biotech Abivax’s might be on the verge of HIV cure and prevention discovery, after achieving a significant reduction of viral load patients during the first 28 days of treatment.
The company has announced results from the first group of patients in its most recent phase 2a trial testing the potential HIV cure treatment codenamed ABX464.
The study aimed at acc...
Among susceptible individuals, statins — which are a common cholesterol-lowering medication — could increase the risk of type 2 diabetes by 30 percent. These new findings are sure to reignite debate. The relationship between statins and diabetes is investigated in a new study.
Statins lower cholesterol by reducing its production in the liver. They do this...
Proton pump inhibitors (PPIs), which include well-known brand names Prilosec, Miracid, Nexium and Prevacid, are among the most commonly prescribed medications in the world. Approximately 10 percent of adults in the United States take these drugs for frequent heartburn, acid reflux and gastroesophageal reflux disease. Given their prevalence, researchers at Skaggs School of Pharmacy and Pharmaceutic...
Neural Analytics, the Los Angeles based company that won FDA clearance a couple of years ago for its Lucid M1 Transcranial Doppler Ultrasound System, now won another clearance, this time for its NeuralBot robotic ultrasound positioner. The two devices work together and when united will be called the Lucid Robotic System.
The NeuralBot automatically positions the ultrasound probe,...